MUCORMICOSE RINO-ORBITO-CEREBRAL EM PACIENTE METABOLICAMENTE DESCOMPENSADO
RELATO DE CASO
Palavras-chave:
Mucormicose; Diabetes Mellitus; Anfotericina B.Resumo
A mucormicose é uma infecção rara causada por fungos Zygomycetes, que se desenvolvem com maior frequência em pacientes imunocomprometidos e diabéticos descompensados. Sua alta morbidade é justificada por ser uma infecção angioinvasiva, que causa trombose e necrose dos tecidos. O relato apresenta quadro clínico de um paciente diabético, masculino, 46 anos, encaminhado a um hospital devido à hipótese de celulite odontogênica, que foi diagnosticado com mucormicose rino-orbito-cerebral. Foi administrada Anfotericina B e o paciente submetido desbridamentos cirúrgicos. O paciente evoluiu com lesão isquêmica aguda cerebelar direita e do troco cerebral ipsilateral, sendo elegível aos cuidados paliativos, seguido por óbito.
Downloads
Referências
ANDREANI, G. et al. Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease. Mediterranean Journal of Hematology and Infectious Diseases, v. 11, n. 1, 2019. e2019061.
BADIN. D. J. et al. The elusive nature of mucormycosis in an immunocompetent host and the role of a dermatology consult. Clinical Case Reports, v. 7, n. 11, p. 2187-2189, 2019.
BELLANGER, A. P. et al. Statin Concentrations Below the Minimum Inhibitory Concentration Attenuate the Virulence of Rhizopus oryzae. The Journal of Infectious Diseases, v. 214, n. 1, p. 114-124, 2016.
BIENFANG, D. C.; KARLUK D. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 9-2002. An 80-year-old woman with sudden unilateral blindness. The New N Engl J Med, v. 346, n. 12, p. 924-929, 2002.
CASE RECORDS OF THE MASSACHUSETTS GENERAL HOSPITAL. Weekly clinicopathological exercises. Case 3-2001. A 59-year-old diabetic man with unilateral visual loss and oculomotor-nerve palsy. The New England Journal of Medicine, v. 344, n. 4, p. 286-293, 2001.
CHEN, Q. et al. Disseminated mucormycosis with cerebellum involvement due to Rhizomucor pusillus in a patient with multiple myeloma and secondary myelodysplastic syndrome: A case report. Experimental and Therapeutic Medicine, v. 18, n. 5, p. 4076-4080, 2019.
CORNELY, O. A. et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. The Lancet. Infectious Diseases, v. 19, n. 12, p. e405-e421, 2019.
FARMAKIOTIS, D.; KONTOYIANNIS, D. P. Mucormycoses. Infectious disease clinics of North America, v. 36, n. 1, p. 143-163, 2016.
GARGOURI, M. et al. Combination of amphotericin B and caspofungin in the treatment of mucormycosis. Med Mycol Case Rep, v. 26, p. 32-37, sep. 2019.
JIANG, Y.; LU, H. From the Pharynx to the Brain: A Case of Rapidly Progressing Mucormycosis. Mycopathologia, v. 184, n. 6. p. 797-798, 2019.
JIMÉNEZ-ZARAZÚA, O. et al. A case of concomitant pulmonary tuberculosis and mucormycosis in an insulin-dependent diabetic patient. Journal of Clinical Tuberculosis and other Mycobacterial Diseases, v. 16, apr. 2019. 100105.
LAM, S. C, YUEN, H. K. L. Management of bilateral rhino-orbital cerebral mucormycosis. Hong Kong Medical Journal, v. 25, n. 5, p. 408-409, 2019.
MCCARTHY, M. W.; DENNING, D. W.; WALSH, T. J. Future Research Priorities in Fungal Resistance. The Journal of Infectious Diseases, v. 216, p. 484-492, 2017. Suppl. 3.
MALEK, A. et al. A Fatal Case of Disseminated Mucormycosis Mimicking a Malignancy. Mycopathologia, v. 184, n. 5, p. 699-700, 2019.
MANE, R. et al. Facial Nerve Palsy: An Unusual Presentation in Patients with Rhino Cerebral Mucormycosis. Indian Journal of Otolaryngology and Head and Neck Surgery, v. 71, p. 2110-2113, 2019. Suppl. 3.
NEVILLE, B. W. et al. Patologia oral e maxilofacial. 4. ed. Rio de Janeiro: Elsevier, 2016. 912 p.
RODRÍGUEZ, J. Y, et al. Necrotizing fasciitis caused by Apophysomyces variabilis in an immunocompetent patient. Medical Mycol ogyCase Reports, v. 20, p. 4-6, dec. 2017.
SHADRIVOVA, O. V.; BURYGINA, E. V.; KLIMKO, N. N. Molecular Diagnostics of Mucormycosis in Hematological Patients: A Literature Review. Journal of Fungi (Basel), v. 5, n. 4, p. 112, nov. 2019.
SINGH, V. P.; BANSAL, C.; KAINTURA, M. Sinonasal Mucormycosis: A to Z. Indian Journal of Otolaryngology and Head and Neck Surgery, v. 71, p. 1962-1971, 2019. Suppl. 3.
SOUZA, J. M. et al. Zigomicose rino facial: relato de caso. Einstein, São Paulo, v. 12, n. 3, p. 347-350, 2014.
TERRY, A. R. et al. Case records of the Massachusetts General Hospital. Case 5-2016. A 43-Year-Old Man with Altered Mental Status and a History of Alcohol Use. The New England Journal of Medicine, v. 374, n. 7, p. 671-680, 2016.
THOMAS, S. et al. Rhinocerebral mucormycosis--a case report. Oral and Maxillofacial Surgery, v. 16, n. 2, p. 233-236, 2012.
TISSOT, F. et al. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Haematologica, v. 102, n. 3, p. 433-444, 2017
TOBÓN, A. M. Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy. Clinical Infectious Diseases, v. 36, n. 11, p. 1488-1491, 2003.
XIA, Z. K.; WANG, W. L.; YANG, R.Y. Slowly progressive cutaneous, rhinofacial, and pulmonary mucormycosis caused by Mucor irregularis in an immunocompetent woman. Clinical Infectious Diseases, v. 56, n. 7, p. 993-995, 2013.
WORLD HEALTH ORGANIZATION. Palliative care. [s.l: WHO, [202-]. Disponível em: https://www.who.int/cancer/palliative/definition/en/. Acesso em: 3 ago. 2020.
ZUGLIAN, G. et al. Cutaneous mucormycosis by Rhizopus arrhizus treated with isavuconazole as first line therapy: A case report. Medical Mycology Case Reports, v. 26, p. 42-43, oct. 2019.
